Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Tabelecleucel in combination with pembrolizumab (Pembro) in platinum-pretreated, recurrent/metastatic Epstein-Barr virus (EBV)-positive nasopharyngeal carcinoma (EBV plus NPC). Siu, L. L., Bauml, J., Adkins, D., Colevas, A., Perez, C., Choe, J., Zhang, Y., Shi, W., Navarro, W. H., Haigentz, M., Rabinowits, G., Pfister, D. G. AMER SOC CLINICAL ONCOLOGY. 2019
View details for DOI 10.1200/JCO.2019.37.15_suppl.TPS6092
View details for Web of Science ID 000487345803410